Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am J Hematol. 2017 Jun 9;92(9):851–857. doi: 10.1002/ajh.24784

Table I.

RBC iron, storage iron, and TBI at enrollment and final visits by group for the 273 subjects included in the paired analysis.

RBC Iron Storage Iron Total Body Iron

Group (n) Enrollment, mg (%) Final, mg (%) ∆, mg (95%C.I.) p Enrollment, mg (%) Final, mg (%) ∆, mg (95%C.I.) p Enrollment, mg Final, mg ∆, mg (95%C.I.) p
No Pills (94) 2172 (84%) 2156 (85%) −16 (−47, 17) 0.34 418 (16%) 379 (15%) −38 (−100, 24) 0.22 2589 2535 −54 (−140, 31) 0.21
Placebo (49) 2064 (85%) 2048 (86%) −16 (−54, 22) 0.41 366 (15%) 325 (14%) −41 (−122, 41) 0.33 2429 2373 −56 (−160, 47) 0.28
19mg (57) 2176 (87%) 2236 (80%) 60 (11, 109) 0.02 335 (13%) 541 (20%) 206 (136, 275) <0.0001 2511 2778 266 (116, 324) <0.0001
38mg (73) 2147 (85%) 2187 (80%) 40 (−1, 82) 0.06 375 (15%) 555 (20%) 180 (107, 253) <0.0001 2523 2743 220 (159, 373) <0.0001

n = 273 is a subset of the larger cohort (n=555) and is comprised of donors with baseline and final visit venous samples available for testing